IE
NURO

Israel Englander’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Israel Englander’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,566
Closed -$30K – 7061
2022
Q4 		$30K Buy
2,566
+1,298
+102% +$18.5K ﹤0.01% 5942
2022
Q3 		$28K Buy
+1,268
New +$34.8K ﹤0.01% 6371
2022
Q1 		– Sell
-1,444
Closed -$58K – 7698
2021
Q4 		$58K Buy
1,444
+141
+11% +$8.34K ﹤0.01% 6441
2021
Q3 		$106K Buy
+1,303
New +$117K ﹤0.01% 6412
2018
Q4 		– Sell
-554
Closed -$59K – 4282
2018
Q3 		$59K Buy
+554
New +$56.2K ﹤0.01% 3795

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return

Israel Englander's NURO Position: Q1 2023 in Review

Israel Englander sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2023, closing a stake of 2,566 shares — an estimated $30K sold.

Israel Englander first reported a position in NURO in Q3 2018 and held it in 5 quarters. The position peaked at $106K in Q3 2021. 12 funds tracked by Wall St. Rank hold NURO as of Q1 2023.

  • Israel Englander reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 2,566 NeuroMetrix, Inc. Common Stock shares in Q1 2023, an estimated $30K.
  • Israel Englander first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Israel Englander's NeuroMetrix, Inc. Common Stock position peaked at $106K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.